Alcon Inc. Ordinary Shares

ALCNYSEUSD
66.91 USD
0.33 (0.50%)🟢PRE MARKET (AS OF 08:53 AM EDT)
🟢Market: OPEN
Open?$68.00
High?$68.00
Low?$66.91
Prev. Close?$66.58
Volume?2.0K
Avg. Volume?2.5M
VWAP?$67.14
Rel. Volume?0.00x
Bid / Ask
Bid?$66.74 × 400
Ask?$66.82 × 400
Spread?$0.08
Midpoint?$66.78
Valuation & Ratios
Market Cap?32.5B
Shares Out?N/A
P/E Ratio?73.80
P/B Ratio?1.66
EPS?$0.90
Dividend?0.00%
Ex-Dividend?N/A

Alcon Inc. Ordinary Shares (ALC) is currently trading at $66.91. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9 and a bearish Death Cross on the long-term moving averages. ALC is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Jun 4, 2026.

RelatedDXCMCOO
News
Profile
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
Employees
25.9K
Market Cap
31.3B
Industry
N/A
Listed
2019-04-09
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-2/3)
Medium-Term (Wave)? Neutral(0/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
94
Momentum?
50
Short Sent.?
41
Piotroski F-Score?0/9Weak
Altman Z-Score?4.27Safe
Confidence?45%Low
Full Fundamental Analysis →
Short InterestLow
Short Interest?6.0M
Days to Cover?2.0
Avg Daily Volume2.9M
Settlement Date2026-05-15
Financial Health
Current Ratio?2.16Strong
Quick Ratio?1.31Adequate
Cash Ratio?0.44Low
Debt/Equity?0.20Low
ValuationFAIRLY VALUEDvs 2 peers + S&P 500
Score
60/100
P/E?
Peers
33
S&P
6
73.8PRICEY
P/B?
Peers
67
S&P
83
1.66CHEAP
P/S?
Peers
67
S&P
40
3.79FAIR
P/FCF?
N/A
EV/EBITDA?
Peers
33
S&P
8
33.3HIGH
EV/Sales?
Peers
67
S&P
45
4.13FAIR
Returns & Efficiency
ROE?
Peers
33
S&P
17
2.3%WEAK
ROA?
Peers
33
S&P
16
1.6%WEAK
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$35.4B
Fundamentals ratios updated end of day